Publications for Wilbert S. Aronow wilbert_aronow@nymc.edu

NYMC School of Medicine
  • Karass, M., Mondal, P., Alkayem, M., Ojo, A., Aronow, W. S., & Puccio, C. (2016). A rare presentation of acute heart failure secondary to aggressive uterine leiomyosarcoma metastatic to the myocardium initially diagnosed as hypertrophic obstructive cardiomyopathy. Annals of Translational Medicine, 4(19), 374. doi:10.21037/atm.2016.09.34

  • Kaur, S., Kumar, A., Lerner, R. G., & Aronow, W. S. (2016). Reversal agents of non-vitamin K dependent anticoagulants: A rapid review of the changing horizon. Archives of Medical Science, 12(5), 1174-1178. doi:10.5114/aoms.2016.61920

  • Khanna, N., Subramanian, K. S., Khera, S., Aronow, W. S., & Frishman, W. H. (2016). New invasive assessment measures of coronary artery disease severity. Cardiology in Review, 24(3), 131-135. doi:10.1097/CRD.0000000000000098

  • Khera, S., Gupta, T., Aronow, W., Subramanian, K., Cooper, H., Timmermans, R., . . . Jain, D. (2016). Temporal trends in utilization of fractional flow reserve for patients with stable coronary artery disease in the United States. Journal of the American College of Cardiology, 67(13), 29. doi:10.1016/S0735-1097(16)30030-4

  • Khera, S., Gupta, T., Kolte, D., Aronow, W., Ahmad, H., Fonarow, G., . . . Bhatt, D. (2016). TCT-382 Temporal trends in incidence and outcomes of acute kidney injury complicating peripheral vascular interventions in the United States. Journal of the American College of Cardiology, 68(18 Suppl), B155. doi:10.1016/j.jacc.2016.09.516

  • Kolte, D., Aronow, W. S., & Banach, M. (2016). Polypills for the prevention of cardiovascular diseases. Expert Opinion on Investigational Drugs, 25(11), 1255-1264. doi:10.1080/13543784.2016.1236912

  • Kolte, D., Khera, S., Aronow, W. S., Timmermans, R., Jain, D., Cooper, H. A., Frishman, W. H., . . . Panza, J. A. (2016). Trends in coronary angiography, revascularization, and outcomes of cardiogenic shock complicating non-ST-elevation myocardial infarction. The American Journal of Cardiology, 117(1), 1-9. doi:10.1016/j.amjcard.2015.10.006

  • Kolte, D., Khera, S., Rizwan Sardar, M., Gheewala, N., Gupta, T., Chatterjee, S., . . . Aronow, W. S. (2016). Thirty-day readmissions after transcatheter aortic valve replacement in the United States: Insights from the Nationwide Readmissions Database. Circulation, 134(Suppl 1), A17798. This material can be found here.

  • Kolte, D., Sardar, P., Khera, S., Aronow, W., Jain, D., Panza, J., . . . Frishman, W. (2016). Culprit only versus multivessel percutaneous coronary intervention in patients with cardiogenic shock complicating acute myocardial infarction: A meta-analysis of observational studies. Journal of the American College of Cardiology, 67(13), 102. This material can be found here.

  • Kundu, A., Sardar, P., Chatterjee, S., Aronow, W. S., Owan, T., & Ryan, J. J. (2016). Minimizing the risk of bleeding with NOACs in the elderly. Drugs & Aging, 33(7), 491-500. doi:10.1007/s40266-016-0376-z

  • Kundu, A., Sardar, P., Ghosh, S., Chatterjee, S., & Aronow, W. (2016). Efficacy and safety of colchicine for prevention of pericarditis and cardiac tamponade: An updated meta-analysis of randomized controlled trials. Journal of the American College of Cardiology, 67(13), 1901. doi:10.1016/S0735-1097(16)31902-7

  • Lai, H. M., Pawar, R., Wolf, D. C., & Aronow, W. S. (2016). Impact of cardiovascular risk factors on long-term mortality after liver transplantation. American Journal of Therapeutics, 23(2), e357-e362. doi:10.1097/MJT.0b013e31829c4c5f

  • Lam, P. H., Arundel, C., Khosla, R., Morgan, C., Zhang, S., Faselis, C., . . . Aronow, W. S. (2016). Early (1-10 days) readmission is associated with a significantly lower 2-12 months post-discharge all-cause mortality among older medicare beneficiaries hospitalized for heart failure with 30-day all-cause readmissions. Journal of the American College of Cardiology, 67(13), 1436. This material can be found here.

  • Lam, P. H., Dooley, D. J., Tsimploulis, A., Arundel, C., Fletcher, R., Butler, J., . . . Aronow, W. S. (2016). Death despite enalapril therapy vs. survival despite placebo in the studies of left ventricular dysfunction (SOLVD) trial: Insights into the role of traditional risk factors for mortality in heart failure and reduced ejection fraction (HFrEF). Circulation, 134(Suppl 1), A20721. This material can be found here.

  • Manickam, R., Manglani, R., Paul, L., & Aronow, W. S. (2016). Extracorporeal membrane oxygenation in respiratory diseases in adults. International Heart and Vascular Diseases Journal, 4(10), 8-16. This material can be found here.

  • McLean, A. W., Khosla, R., Deedwania, P., Iyer, A., Inampudi, C., Morgan, C., . . . Aronow, W. S. (2016). COPD is associated with significantly higher long-term readmission and mortality but has no association with 30-day all-cause or heart failure readmission or all-cause mortality in older Medicare beneficiaries hospitalized for heart failure. American Journal of Respiratory and Critical Care Medicine, 193(Abstract issue), A1127. This material can be found here.

  • Mujib, M., Aronow, W., Khera, S., Gupta, T., Harikrishnan, P., Sule, S., Jain, D., Lanier, G., Cooper, H., Gass, A., Frishman, W., . . . Panza, J. (2016). Sex-related variations in in-hospital outcomes in patients with heart failure receiving left ventricular assist devices: Findings from nationwide inpatient sample study 2002-2012. Journal of the American College of Cardiology, 67(13), 1366. doi:10.1016/S0735-1097(16)31367-5

  • Mujib, M., Aronow, W. S., Khera, S., Gupta, T., Paul, N. M., Sule, S., Lanier, G.Lerner, R. G., Jain, D., Cooper, H., Gass, A., Frishman, W., . . . Panza, J. (2016). Pre-implant coagulopathy and in-hospital mortality among advanced heart failure patients receiving left ventricular assist device: A United States National Study. Journal of the American College of Cardiology, 67(13), 1275. doi:10.1016/S0735-1097(16)31276-1

  • Sanaani, A., Aronow, W. S., Paudel, R., & Cooper, H. (2016). Correlation between electrocardiographic changes and coronary angiography findings in patients with acute myocardial infarction and single-vessel disease. Cardiology, 134(Suppl 1), 343.

  • Serban, M. C., Sahebkar, A., Muntner, P., Howard, G., Ahmed, A., Graham, I., . . . Aronow, W. (2016). The effect of quercetin on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Journal of the American College of Cardiology, 67(13), 2003. doi:10.1016/S0735-1097(16)32004-6

  • Sheriff, H., Lam, P. H., Arundel, C., Dooley, D. J., Panjrath, G., Fletcher, R. D., . . . Aronow, W.S., (2016). Discharge hospice referral is associated with lower 30-day all-cause readmission in hospitalized patients with heart failure: a propensity-matched study of the medicare-linked OPTIMIZE-HF. Circulation, 134(Suppl 1), A20782. This material can be found here.

  • Sheriff, H. M., Thogaripally, M., Arundel, C., Zeng, Q., Blackman, M., Aronow, W. S., & Ahmed, A. (2016). Digoxin and 30-day all-cause readmissions for nursing home residents hospitalized for heart failure. Gerontologist, 56(Suppl 3), 149. doi:10.1093/geront/gnw162.592

  • Tomer, M. M., Gannuscio, J., Valentova, M., Fonarow, G., Adamopoulos, C., Kanonidis, I., . . . Aronow, W. (2016). Duration of heart failure and outcomes in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 18(Suppl 1), 196-197.

  • Tsimploulis, A., Lam, P. H., Dooley, D., Weerakoon, S., Arundel, C., Fletcher, R. D., . . . Aronow W. S. (2016). Lower discharge systolic blood pressure (SBP) and poor outcomes among hospitalized patients with heart failure and preserved ejection fraction (HFpEF) and stable admission-to-discharge SBP. Circulation, 134(Suppl 1), A20566. This material can be found here.

  • Tsimploulis, A., Weerakoon, S., Valentova, M., Morgan, C., Blackman, M. R., Butler, J., . . . Aronow, W. S. (2016). Baseline hypokalemia and long-term outcomes in ambulatory patients with heart failure with reduced ejection fraction (HFrEF) and New York Heart Association Class III-IV: a propensity-matched study of Beta-blocker valuation of Survival Trial (BEST). Journal of Cardiac Failure, 22(Suppl 8), S87. doi:10.1016/j.cardfail.2016.06.278

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last